Search

Search bills, members, committees and pages...

H.R. 7528

U.S. HouseIn House Committee

Summary

H.R. 7528, the GAP Supply Act, was introduced in the House on Feb 12, 2026 by Rep. Earl Carter (R). It was referred to Energy And Commerce, and last saw action on Feb 12, 2026: Referred to the House Committee on Energy and Commerce.


Record

Text

H.R. 7528 has no co-sponsors and has not gone to a roll call.

hb7528/introduced-in-house.txt
119 HR 7528 IH: Growing America’s Pharmaceutical Supply Act
U.S. House of Representatives
2026-02-12
text/xml
EN
Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
I 119th CONGRESS 2d Session H. R. 7528 IN THE HOUSE OF REPRESENTATIVES February 12, 2026 Mr. Carter of Georgia introduced the following bill; which was referred to the Committee on Energy and Commerce A BILL
To amend section 503B of the Federal Food, Drug, and Cosmetic Act to enhance the ability of outsourcing facilities to mitigate drug shortages by allowing a short-term period to continue supplying the market after a drug is in shortage.
1.
Short title
This Act may be cited as the Growing America’s Pharmaceutical Supply Act or the GAP Supply Act .
2.
Providing for a tail period for outsourcing facilities to compound and distribute drugs in shortage
Section 503B of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 353b ) is amended—
(1)
in subsection (a)(2)(A)(ii), by striking at the time and inserting within 180 calendar days ; and
(2)
in subsection (d)(2)(A), by striking at the time and inserting within 180 calendar days .

Tracker

The tracker indicates the progress of this legislation as it moves through the legislative process.

  1. Introduced2026-02-12
  2. Passed House
  3. Passed Senate
  4. Conference
  5. To President
  6. Became Law

To amend section 503B of the Federal Food, Drug, and Cosmetic Act to enhance the ability of outsourcing facilities to mitigate drug shortages by allowing a short-term period to continue supplying the market after a drug is in shortage.

Sponsors

Rep. Earl Carter (R) sponsors H.R. 7528 alone.

Committees

H.R. 7528 went before 1 committee: Energy and Commerce.

Energy and Commerce
Energy and Commerce
Referred To · Feb 12, 2026 · 1,636 Bills

Actions

H.R. 7528 has taken 2 actions since Feb 12, 2026.

ChamberAction
Feb 12, 2026
House
Introduced in House
Feb 12, 2026
House
Referred to the House Committee on Energy and Commerce.Energy and Commerce Committee

Votes

H.R. 7528 has not gone to a roll call.

Titles

H.R. 7528 goes by 4 titles, 2 of them short titles.

  • GAP Supply Act — Display Title
  • GAP Supply Act — Short Title(s) as Introduced
  • Growing America’s Pharmaceutical Supply Act — Short Title(s) as Introduced
  • To amend section 503B of the Federal Food, Drug, and Cosmetic Act to enhance the ability of outsourcing facilities to mitigate drug shortages by allowing a short-term period to continue supplying the market after a drug is in shortage. — Official Title as Introduced

Lobbying

1 client hired 1 firm and 10 registered lobbyists who named H.R. 7528 in 2 quarterly filings, 2025. Reported under the Lobbying Disclosure Act; a filing’s income covers everything its registrant worked that quarter, so the amounts below are the filings’, not this bill’s.

Filed under Banking, Budget/Appropriations, Civil Rights/Civil Liberties, Consumer Issues/Safety/Products, Government Issues, Health Issues, Labor Issues/Antitrust/Workplace, Pharmacy.

Clients

Who paid to be heard, by how many filings named the bill.

ClientBusinessStateFirmsFilingsReported
PUBLIC CITIZENDistrict of Columbia12

Firms

Registrants who filed on the bill, by filings.

RegistrantClientsFilingsReported
PUBLIC CITIZEN12

Lobbyists

Named on the filings that cite the bill.

Filings

The documents themselves, on the Senate’s Lobbying Disclosure site, largest reported first.

ClientRegistrantPeriodReportedDocument
PUBLIC CITIZENPUBLIC CITIZEN2025 second_quarter$98.8K2nd Quarter - Report
PUBLIC CITIZENPUBLIC CITIZEN2025 first_quarter$76.6K1st Quarter - Report

Classification

The Congressional Research Service files H.R. 7528 under Health, one of its 31 policy areas.

CRS Subjects

CRS assigns every bill one policy area from its 31; H.R. 7528’s is Health.

hr7528/policy-areas.txt
HealthAgriculture and FoodAnimalsArmed Forces and National SecurityArts, Culture, ReligionCivil Rights and Liberties, Minority IssuesCommerceCongressCrime and Law EnforcementEconomics and Public FinanceEducationEmergency ManagementEnergyEnvironmental ProtectionFamiliesFinance and Financial SectorForeign Trade and International FinanceGovernment Operations and PoliticsHousing and Community DevelopmentImmigrationInternational AffairsLabor and EmploymentLawNative AmericansPublic Lands and Natural ResourcesScience, Technology, CommunicationsSocial WelfareSports and RecreationTaxationTransportation and Public WorksWater Resources Development

Constitutional authority

The clause the sponsor cites as Congress’s power to enact H.R. 7528, as entered in the Congressional Record.

[Congressional Record Volume 172, Number 30 (Thursday, February 12, 2026)][House]From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]By Mr. CARTER of Georgia:H.R. 7528.Congress has the power to enact this legislation pursuantto the following:Article 1, Section 8 of the Constitution[Page H2220]

Source: congress.gov · legiscan.com